(+)-dexrazoxane decreases expression ISO RGD:1552757 6480464 Dexrazoxane results in decreased expression of HADHA mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HADHA mRNA] CTD PMID:31150632 (R)-carnitine multiple interactions ISO RGD:733877 6480464 Carnitine inhibits the reaction [quinone results in decreased expression of HADHA protein] CTD PMID:32478940 1,2-dimethylhydrazine decreases expression ISO RGD:1552757 6480464 1, 2-Dimethylhydrazine results in decreased expression of HADHA mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1552757 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HADHA mRNA CTD PMID:22206623 1,4-benzoquinone decreases expression ISO RGD:733877 6480464 quinone results in decreased expression of HADHA mRNA, quinone results in decreased expression of HADHA protein CTD PMID:32478940 1,4-benzoquinone multiple interactions ISO RGD:733877 6480464 Carnitine inhibits the reaction [quinone results in decreased expression of HADHA protein] CTD PMID:32478940 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:733877 6480464 Dinitrochlorobenzene binds to HADHA protein CTD PMID:32991956 1-naphthyl isothiocyanate multiple interactions ISO RGD:1552757 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of HADHA mRNA, Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of HADHA mRNA] CTD PMID:33749747 1-naphthyl isothiocyanate decreases expression ISO RGD:1552757 6480464 1-Naphthylisothiocyanate results in decreased expression of HADHA mRNA CTD PMID:33749747 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HADHA mRNA CTD PMID:16174780 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733877 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HADHA mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HADHA mRNA CTD PMID:34747641 2,4,6-tribromophenol decreases expression ISO RGD:733877 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of HADHA mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HADHA mRNA CTD PMID:21346803 2-acetamidofluorene multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of HADHA mRNA CTD PMID:16158176 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:733877 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of HADHA protein CTD PMID:32044396 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1552757 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1552757 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of HADHA mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1552757 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of HADHA mRNA CTD PMID:23428407 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1552757 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of HADHA exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:733877 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HADHA protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO RGD:1552757 6480464 Fenretinide results in increased expression of HADHA mRNA CTD PMID:28973697 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:733877 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions ISO RGD:1552757 6480464 [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of HADHA mRNA CTD PMID:33749747 7,9-dihydro-1H-purine-2,6,8(3H)-trione decreases expression ISO RGD:1552757 6480464 Uric Acid results in decreased expression of HADHA mRNA CTD PMID:33749747 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of HADHA mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:733877 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HADHA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HADHA mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1552757 6480464 Aflatoxin B1 results in increased expression of HADHA mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:733877 6480464 Aflatoxin B1 results in decreased methylation of HADHA gene CTD PMID:27153756 allopurinol multiple interactions ISO RGD:1552757 6480464 Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of HADHA mRNA] CTD PMID:33749747 alpha-pinene multiple interactions ISO RGD:733877 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HADHA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HADHA mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HADHA mRNA CTD PMID:16483693 aspartame multiple interactions ISO RGD:1552757 6480464 [Fats more ... CTD PMID:23783067 atrazine decreases expression ISO RGD:733877 6480464 Atrazine results in decreased expression of HADHA mRNA CTD PMID:22378314 bathocuproine disulfonic acid multiple interactions ISO RGD:733877 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA] CTD PMID:15477007 benzo[a]pyrene decreases expression ISO RGD:733877 6480464 Benzo(a)pyrene results in decreased expression of HADHA protein CTD PMID:33278487 bezafibrate increases expression ISO RGD:1552757 6480464 Bezafibrate results in increased expression of HADHA mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1552757 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HADHA mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of HADHA mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552757 6480464 Diethylhexyl Phthalate results in increased expression of HADHA mRNA CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HADHA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:733877 6480464 bisphenol A results in decreased expression of HADHA protein CTD PMID:31675489 , PMID:34186270 Bisphenol B increases expression ISO RGD:733877 6480464 bisphenol B results in increased expression of HADHA protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733877 6480464 bisphenol F results in increased expression of HADHA protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of HADHA protein CTD PMID:25933445 bortezomib increases expression ISO RGD:733877 6480464 Bortezomib results in increased expression of HADHA mRNA CTD PMID:20977926 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of HADHA protein CTD PMID:28903499 caffeine decreases phosphorylation ISO RGD:733877 6480464 Caffeine results in decreased phosphorylation of HADHA protein CTD PMID:35688186 ciglitazone multiple interactions ISO RGD:733877 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of HADHA mRNA, [ciglitazone binds to PPARG protein] which results in increased expression of HADHA mRNA CTD PMID:16197558 ciguatoxin CTX1B affects expression ISO RGD:1552757 6480464 Ciguatoxins affects the expression of HADHA mRNA CTD PMID:18353800 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of HADHA protein CTD PMID:20118634 clofibrate increases expression ISO RGD:1552757 6480464 Clofibrate results in increased expression of HADHA mRNA, Clofibrate results in increased expression of HADHA protein CTD PMID:21338618 , PMID:23811191 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of HADHA mRNA CTD PMID:12851107 , PMID:18670166 Clofop multiple interactions ISO RGD:733877 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of HADHA mRNA CTD PMID:16197558 cyclosporin A decreases expression ISO RGD:1552757 6480464 Cyclosporine results in decreased expression of HADHA mRNA CTD PMID:19770486 , PMID:23830897 cyclosporin A decreases expression ISO RGD:733877 6480464 Cyclosporine results in decreased expression of HADHA mRNA CTD PMID:20106945 , PMID:23830897 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA CTD PMID:29038839 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of HADHA mRNA CTD PMID:23640034 decabromodiphenyl ether decreases expression ISO RGD:733877 6480464 decabromobiphenyl ether results in decreased expression of HADHA protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1552757 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of HADHA mRNA CTD PMID:23428407 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of HADHA mRNA CTD PMID:21266533 diethyldithiocarbamic acid decreases expression EXP 6480464 Ditiocarb results in decreased expression of HADHA protein CTD PMID:22874009 disodium selenite increases expression ISO RGD:733877 6480464 Sodium Selenite results in increased expression of HADHA mRNA CTD PMID:18175754 doxorubicin decreases expression ISO RGD:1552757 6480464 Doxorubicin results in decreased expression of HADHA mRNA CTD PMID:26873546 elemental selenium decreases expression ISO RGD:733877 6480464 Selenium results in decreased expression of HADHA mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:733877 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HADHA protein CTD PMID:23301498 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA CTD PMID:29038839 ethanol increases expression ISO RGD:1552757 6480464 Ethanol results in increased expression of HADHA mRNA CTD PMID:30319688 farnesol multiple interactions ISO RGD:733877 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHA mRNA CTD PMID:30611723 farnesol increases expression ISO RGD:733877 6480464 Farnesol analog results in increased expression of HADHA mRNA CTD PMID:30611723 fenofibrate increases expression ISO RGD:1552757 6480464 Fenofibrate results in increased expression of HADHA mRNA CTD PMID:17118139 fenofibrate increases expression ISO RGD:733877 6480464 Fenofibrate results in increased expression of HADHA mRNA CTD PMID:25572481 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of HADHA protein CTD PMID:20118634 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of HADHA mRNA CTD PMID:16707586 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of HADHA mRNA CTD PMID:30307764 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of HADHA mRNA CTD PMID:23962444 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of HADHA mRNA CTD PMID:18035473 flutamide decreases expression ISO RGD:1552757 6480464 Flutamide results in decreased expression of HADHA mRNA CTD PMID:17702527 , PMID:19442681 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of HADHA mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1552757 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HADHA mRNA CTD PMID:22206623 furan decreases expression EXP 6480464 furan results in decreased expression of HADHA mRNA CTD PMID:27387713 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of HADHA mRNA CTD PMID:15345336 GW 4064 multiple interactions ISO RGD:733877 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of HADHA mRNA CTD PMID:30611723 GW 501516 multiple interactions ISO RGD:733877 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA CTD PMID:16197558 GW 7647 multiple interactions ISO RGD:733877 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of HADHA mRNA, GW 7647 promotes the reaction [Oleic Acid results in increased expression of HADHA mRNA] CTD PMID:30611723 GW 7647 increases expression ISO RGD:733877 6480464 GW 7647 results in increased expression of HADHA mRNA CTD PMID:30611723 ionomycin multiple interactions ISO RGD:733877 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA CTD PMID:15477007 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of HADHA mRNA CTD PMID:30303030 ivermectin decreases expression ISO RGD:733877 6480464 Ivermectin results in decreased expression of HADHA protein CTD PMID:32959892 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of HADHA mRNA CTD PMID:15372504 lamivudine multiple interactions ISO RGD:1552757 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of HADHA mRNA CTD PMID:18313992 lead(0) decreases expression ISO RGD:733877 6480464 Lead results in decreased expression of HADHA mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:733877 6480464 Lead results in decreased expression of HADHA mRNA CTD PMID:19921347 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of HADHA mRNA CTD PMID:24136188 linsidomine increases oxidation EXP 6480464 linsidomine results in increased oxidation of HADHA protein CTD PMID:28086193 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of HADHA mRNA CTD PMID:30467583 methotrexate increases expression ISO RGD:733877 6480464 Methotrexate results in increased expression of HADHA mRNA CTD PMID:17400583 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1552757 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of HADHA mRNA CTD PMID:32522588 monosodium L-glutamate multiple interactions ISO RGD:1552757 6480464 [Fats more ... CTD PMID:23783067 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of HADHA mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of HADHA mRNA CTD PMID:16158176 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of HADHA protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of HADHA mRNA CTD PMID:24136188 oleic acid multiple interactions ISO RGD:733877 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 oleic acid increases expression ISO RGD:733877 6480464 Oleic Acid results in increased expression of HADHA mRNA CTD PMID:30611723 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of HADHA mRNA CTD PMID:30316929 ozone multiple interactions ISO RGD:733877 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HADHA mRNA more ... CTD PMID:32699268 perflubutane affects expression ISO RGD:733877 6480464 perfluorobutane affects the expression of HADHA mRNA CTD PMID:23567314 perfluorobutanesulfonic acid decreases expression EXP 6480464 perfluorobutanesulfonic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorobutanesulfonic acid increases expression ISO RGD:733877 6480464 perfluorobutanesulfonic acid results in increased expression of HADHA mRNA CTD PMID:33772556 perfluorobutyric acid decreases expression EXP 6480464 perfluorobutyric acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorodecanoic acid affects expression ISO RGD:733877 6480464 perfluorodecanoic acid affects the expression of HADHA mRNA CTD PMID:23567314 perfluorododecanoic acid affects expression ISO RGD:733877 6480464 perfluorododecanoic acid affects the expression of HADHA mRNA CTD PMID:23567314 perfluorododecanoic acid multiple interactions EXP 6480464 PPARA mRNA promotes the reaction [perfluorododecanoic acid results in increased expression of HADHA mRNA] CTD PMID:26168851 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of HADHA mRNA, perfluorododecanoic acid results in increased expression of HADHA protein CTD PMID:26168851 perfluorododecanoic acid affects expression EXP 6480464 perfluorododecanoic acid affects the expression of HADHA mRNA CTD PMID:22071372 perfluoroheptanoic acid increases expression ISO RGD:733877 6480464 perfluoro-n-heptanoic acid results in increased expression of HADHA mRNA CTD PMID:23567314 perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorohexanesulfonic acid affects expression ISO RGD:733877 6480464 perfluorohexanesulfonic acid affects the expression of HADHA mRNA CTD PMID:23567314 perfluorohexanoic acid decreases expression EXP 6480464 perfluorohexanoic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorohexanoic acid increases expression ISO RGD:733877 6480464 perfluorohexanoic acid results in increased expression of HADHA mRNA CTD PMID:23567314 perfluorononanoic acid increases expression ISO RGD:733877 6480464 perfluoro-n-nonanoic acid results in increased expression of HADHA mRNA CTD PMID:23567314 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of HADHA mRNA CTD PMID:22071372 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of HADHA mRNA CTD PMID:18692542 , PMID:19162173 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorooctane-1-sulfonic acid increases expression ISO RGD:733877 6480464 perfluorooctane sulfonic acid results in increased expression of HADHA mRNA CTD PMID:23567314 , PMID:33772556 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1552757 6480464 perfluorooctane sulfonic acid results in increased expression of HADHA mRNA CTD PMID:19429403 , PMID:20936131 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HADHA mRNA, perfluorooctanoic acid results in increased expression of HADHA protein CTD PMID:16221955 more ... perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluorooctanoic acid increases expression ISO RGD:733877 6480464 perfluorooctanoic acid results in increased expression of HADHA mRNA CTD PMID:23567314 more ... perfluorooctanoic acid multiple interactions ISO RGD:1552757 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of HADHA mRNA] CTD PMID:18467677 , PMID:20936131 perfluorooctanoic acid increases expression ISO RGD:1552757 6480464 perfluorooctanoic acid results in increased expression of HADHA mRNA CTD PMID:17681415 more ... perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of HADHA mRNA CTD PMID:22071372 perfluoroundecanoic acid affects expression ISO RGD:733877 6480464 perfluoroundecanoic acid affects the expression of HADHA mRNA CTD PMID:23567314 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of HADHA mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:1552757 6480464 Phenobarbital affects the expression of HADHA mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of HADHA mRNA CTD PMID:12082028 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733877 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA], [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA CTD PMID:15477007 pirinixic acid multiple interactions ISO RGD:1552757 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of HADHA mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of HADHA mRNA] CTD PMID:18467677 , PMID:20813756 pirinixic acid increases expression ISO RGD:1552757 6480464 pirinixic acid results in increased expression of HADHA mRNA CTD PMID:16357043 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HADHA mRNA CTD PMID:16707586 more ... pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of HADHA mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:1552757 6480464 Pravastatin results in decreased expression of HADHA mRNA CTD PMID:27225895 pyrrolidine dithiocarbamate multiple interactions ISO RGD:733877 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA] CTD PMID:15477007 rotenone increases expression EXP 6480464 Rotenone results in increased expression of HADHA mRNA, Rotenone results in increased expression of HADHA protein CTD PMID:28374803 , PMID:35544339 sarin decreases expression ISO RGD:733877 6480464 Sarin results in decreased expression of HADHA mRNA CTD PMID:19522546 SB 431542 increases expression ISO RGD:733877 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HADHA protein CTD PMID:25670856 selenium atom decreases expression ISO RGD:733877 6480464 Selenium results in decreased expression of HADHA mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:1552757 6480464 Silver results in increased expression of HADHA mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1552757 6480464 Silver results in increased expression of HADHA mRNA CTD PMID:27131904 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HADHA protein CTD PMID:29459688 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of HADHA mRNA CTD PMID:21515302 testosterone enanthate affects expression ISO RGD:733877 6480464 testosterone enanthate affects the expression of HADHA mRNA CTD PMID:17440010 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of HADHA mRNA CTD PMID:15963342 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HADHA mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HADHA mRNA] CTD PMID:31150632 tetracycline increases expression ISO RGD:1552757 6480464 Tetracycline results in increased expression of HADHA mRNA CTD PMID:16917069 tetracycline decreases expression ISO RGD:1552757 6480464 Tetracycline results in decreased expression of HADHA mRNA CTD PMID:24489787 thapsigargin increases expression ISO RGD:1552757 6480464 Thapsigargin results in increased expression of HADHA protein CTD PMID:24648495 thimerosal decreases expression ISO RGD:733877 6480464 Thimerosal results in decreased expression of HADHA mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of HADHA mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1552757 6480464 titanium dioxide results in increased expression of HADHA mRNA CTD PMID:29264374 tributylstannane increases expression ISO RGD:1552757 6480464 tributyltin results in increased expression of HADHA mRNA CTD PMID:23428407 triptonide increases expression ISO RGD:1552757 6480464 triptonide results in increased expression of HADHA mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of HADHA mRNA CTD PMID:21515302 valproic acid decreases methylation ISO RGD:733877 6480464 Valproic Acid results in decreased methylation of HADHA gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733877 6480464 Valproic Acid affects the expression of HADHA mRNA CTD PMID:25979313 vitamin E decreases expression ISO RGD:733877 6480464 Vitamin E results in decreased expression of HADHA mRNA CTD PMID:19244175 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of HADHA mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:1552757 6480464 squalestatin 1 affects the expression of HADHA mRNA CTD PMID:27225895 zidovudine multiple interactions ISO RGD:1552757 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of HADHA mRNA CTD PMID:18313992 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of HADHA mRNA CTD PMID:15671213 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of HADHA mRNA CTD PMID:15671213 zoledronic acid decreases expression ISO RGD:1552757 6480464 zoledronic acid results in decreased expression of HADHA mRNA CTD PMID:28871336
